Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Patient Preference and Adherence
|
March 8, 2022
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States
Daniel Auclair, Carol Mansfield, Mark A Fiala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Iskra Pusic, Jaebok Choi, Mark A Fiala, et al.
Leukemia & Lymphoma
|
May 14, 2013
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Tzu-Fei Wang, Rohan Ahluwalia, Mark A Fiala, et al.
Gynecologic Oncology
|
March 2, 2021
A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy
Mary M Mullen, Tyler R McKinnish, Mark A Fiala, et al.
Leukemia Research
|
August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
Armin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Blood Advances
|
October 7, 2025
Ablation of CD38 in Multiple Myeloma Cells Leads to an Aggressive Phenotype in a Mouse Xenograft Model
Michael Riley Dyer, Alexander Zheleznyak, Erin N Teubner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
Transplantation and Cellular Therapy
|
August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Ziheng Xu, Jaebok Choi, Matthew Cooper, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Somatic mutation phasing and haplotype extension using linked-reads in multiple myeloma
Steven M Foltz, Yize Li, Lijun Yao, et al.
Leukemia
|
March 13, 2019
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
Ujjawal H Gandhi, Robert F Cornell, Arjun Lakshman, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Patient Preference and Adherence
|
March 8, 2022
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States
Daniel Auclair, Carol Mansfield, Mark A Fiala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Iskra Pusic, Jaebok Choi, Mark A Fiala, et al.
Leukemia & Lymphoma
|
May 14, 2013
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Tzu-Fei Wang, Rohan Ahluwalia, Mark A Fiala, et al.
Gynecologic Oncology
|
March 2, 2021
A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy
Mary M Mullen, Tyler R McKinnish, Mark A Fiala, et al.
Leukemia Research
|
August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
Armin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Blood Advances
|
October 7, 2025
Ablation of CD38 in Multiple Myeloma Cells Leads to an Aggressive Phenotype in a Mouse Xenograft Model
Michael Riley Dyer, Alexander Zheleznyak, Erin N Teubner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
Transplantation and Cellular Therapy
|
August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Ziheng Xu, Jaebok Choi, Matthew Cooper, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Somatic mutation phasing and haplotype extension using linked-reads in multiple myeloma
Steven M Foltz, Yize Li, Lijun Yao, et al.
Leukemia
|
March 13, 2019
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
Ujjawal H Gandhi, Robert F Cornell, Arjun Lakshman, et al.
Page
of 8